The mixed financial results for Q4 suggest that while some aspects of Pactiv Evergreen's business may be performing well, others are not meeting expectations. This discrepancy can lead to investor uncertainty and a lack of confidence in the company's short-term growth prospects, thus negatively affecting the stock price.